Ethics approval and consent to participate {24}
-20
The proposed research is a multicentre pragmatic clinical study that includes humans and the handling of personal data. The entire study will be carried out in Sweden. Written, informed consent to participate will be obtained from all participants.Ethical approval and completion of the ethical approval for the proposed multicentre RCT were approved by the Swedish Ethical Review Authority on 2021–04-26 with Dnr 2021–01880 and on 2022–01-26 with Dnr 2021–07010-02. Further ethical approval was granted on 2022–03-26 with Dnr 2022–01503-02, on 2023–01-18 with Dnr 023–00021-02 and on 2023–07-20 with Dnr 2023–03925-02.Clinical trial registration was prospectively performed on 2021–06-04, with the ClinicalTrials.gov identifier NCT04915027.